Showing results (191-200 of 199) with videos related to
Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 199 results.
Worldviews on Evidence-Based Nursing|January 8, 2023
A scoping review on the nurse scientist role within healthcare systemsDeborah H Allen, Elizabeth K Arthur, Meghan Blazey, et al.Cell Host & Microbe|May 21, 2013
The Mtb proteome library: a resource of assays to quantify the complete proteome of Mycobacterium tuberculosisOlga T Schubert, Jeppe Mouritsen, Christina Ludwig, et al.Journal of the American Geriatrics Society|April 7, 2025
Scaling Alzheimer's Care: The Case for Specialized Treatment ClinicsEric D Vidoni, Adam C Parks, Amanda Brunette, et al.Biopreservation and Biobanking|May 25, 2026
Operationalizing AD Biomarker Return of Research Results: Methods from the KU ADRCEric D Vidoni, Jonathan D Mahnken, Jill K Morris, et al.Genome Research|July 3, 2014
Diverse patterns of genomic targeting by transcriptional regulators in Drosophila melanogasterMatthew Slattery, Lijia Ma, Rebecca F Spokony, et al.Leukemia|October 14, 2018
Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cellsDavid M Ross, Ilaria S Pagani, Naranie Shanmuganathan, et al.British Journal of Haematology|December 23, 2025
The PINNACLE study: A multicentre phase II trial of nilotinib in combination with pegylated interferon-α2b in newly diagnosed chronic phase chronic myeloid leukaemiaDavid T Yeung, Andrew P Grigg, John Reynolds, et al.Blood|December 19, 2014
TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targetsDavid T Yeung, Michael P Osborn, Deborah L White, et al.JCO Precision Oncology|August 9, 2018
Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II/III colorectal cancer patients who benefit from adjuvant chemotherapyW L Allen, P D Dunne, S McDade, et al.Pageof 20